Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis

por Xia, Handai, Zhang, Wengang, Zhang, Yuqing, Shang, Xiaoling, Liu, Yanguo, Wang, Xiuwen
Publicado 2022

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutations

por Shang, Xiaoling, Zhang, Wengang, Han, Wenfei, Xia, Handai, Liu, Ni, Wang, Xiuwen, Liu, Yanguo
Publicado 2023

Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysi...

por Xia, Handai, Zhang, Wengang, Zheng, Qi, Zhang, Yuqing, Mu, Xin, Wei, Chenxi, Wang, Xiuwen, Liu, Yanguo
Publicado 2023

Targeted paclitaxel‐octreotide conjugates inhibited the growth of paclitaxel‐resistant human non‐small cell lung cancer A549 cells in vitro

por Liu, Yanguo, Xia, Handai, Wang, Yawei, Han, Wenfei, Qin, Jing, Gao, Wenjuan, Qu, Xun, Wang, Xiuwen
Publicado 2021

CDC25C as a Predictive Biomarker for Immune Checkpoint Inhibitors in Patients With Lung Adenocarcinoma

por Zhang, Wengang, Shang, Xiaoling, Yang, Fei, Han, Wenfei, Xia, Handai, Liu, Ni, Liu, Yanguo, Wang, Xiuwen
Publicado 2022

ANK2 as a novel predictive biomarker for immune checkpoint inhibitors and its correlation with antitumor immunity in lung adenocarcinoma

por Zhang, Wengang, Shang, Xiaoling, Liu, Ni, Ma, Xinchun, Yang, Rui, Xia, Handai, Zhang, Yuqing, Zheng, Qi, Wang, Xiuwen, Liu, Yanguo
Publicado 2022

Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma

por Zhang, Wengang, Xia, Handai, Yang, Rui, Zhang, Yuqing, Zheng, Qi, Shang, Xiaoling, Liu, Ni, Ma, Xinchun, Wei, Chenxi, Chen, Hang, Mu, Xin, Wang, Xiuwen, Liu, Yanguo
Publicado 2022